How to assess and compare drugs in the management of migraine: Success rates in terms of response and recurrence

Cephalalgia, Supplement

Volumn 19, Issue 23, 1999, Pages 2-8

  Ferrari, Michel ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; ERGOTAMINE; PARACETAMOL; PLACEBO; SUMATRIPTAN; ZOLMITRIPTAN;

ANALGESIA; CONTROLLED STUDY; DISEASE DURATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HEADACHE; HUMAN; MIGRAINE; PRACTICE GUIDELINE; RECURRENCE RISK; REVIEW; TREATMENT PLANNING;

EID: 0032989190     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1177/0333102499019s2302     Document Type: Review

References (2)

1. Tfelt-Hansen P. How to define the best efficacy parameters for migraine. Cephalalgia 1997;17 Suppl 17:6-9
2. Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice: a two year review of 453 migraine patients. Neurology 1996;47:46-51